Professor Arnon Nagler
Hematologist-oncologist. Arnon Nagler is a world-renowned Israeli hemato-oncologist specializing in the treatment of blood cancer and bone marrow transplantation. Director of the Hematology, Bone Marrow Transplantation and Cord Blood Bank Division at Sheba Medical Center.
Arnon Nagler graduated from the Faculty of Medicine of the Hebrew University of Jerusalem.
He specialized further in internal medicine and hematology at Rambam Medical Center in Haifa, and trained in hematology and bone marrow transplantation at Stanford University (USA). He also graduated with distinction with a master's degree in cell biology and hematology from Tel Aviv University.
Professor Nagler is a member of the American Society of Hematology and the International Society for Bone Marrow Transplantation. For many years he has also been chairman of the Israeli Society for Bone Marrow Transplantation.
Today Arnon Nagler heads the Hematology, Bone Marrow Transplantation and Cord Blood Bank Division at Sheba Medical Center.
Arnon Nagler is an innovative physician who stood at the origin of research into, and practical application of, bone marrow transplantation after chemotherapy. This landmark discovery was later also applied effectively to elderly people. In his practice he uses the latest achievements of modern medicine, including immunotherapy with NK cells (natural killer cells), as well as unique methods of his own. Professor Nagler performed the first cord blood transplant in Israel. At the same time he created the country's first cord blood bank at Sheba Medical Center.
Arnon Nagler is an outstanding research scientist who has received more than 50 grants for hematology research from the Israeli government, medical associations and foundations. These studies have resulted in more than 400 articles in leading medical journals. His most important scientific achievements have been recognized with numerous international and national awards.
Professor Nagler teaches successfully, giving a lecture course to medical students at Tel Aviv University. He is also a member of the scientific boards of leading biotechnology corporations in Israel.
- Lymphogranulomatosis
- Acute lymphoblastic leukemia
- Acute myeloblastic leukemia
- Chronic myeloid leukemia
- Chronic lymphocytic leukemia
- Multiple myeloma
- Hodgkin lymphoma
- Non-Hodgkin lymphomas